載入...
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572849/ https://ncbi.nlm.nih.gov/pubmed/33123161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.577869 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|